Abused inhalants are widely used, especially among school-age children and teenagers, and are ‘gateway’ drugs leading to the abuse of alcohol and other addictive substances. In spite of this widespread use, little is known about the effects produced by inhalants on the central nervous system. The similarity in behavioral effects produced by inhalants and inhaled anesthetics, together with their common chemical features, prompted this study of inhalant actions on a well-characterized anesthetic target, GABA synapses. Whole-cell patch clamp recordings were conducted on CA1 pyramidal neurons in rat hippocampal brain slices to measure effects on resting membrane properties, action potential discharge, and GABA-mediated inhibitory responses. Toluene, 1,1,1-trichloroethane, and trichloroethylene depressed CA1 excitability in a concentration-dependent and reversible manner. This depression appeared to involve enhanced GABA-mediated inhibition, evident in its reversal by a GABA receptor antagonist. Consistent with this, the abused inhalants increased inhibitory postsynaptic potentials produced using minimal stimulation of stratum radiatum inputs to CA1 neurons, in the presence of CNQX and APV to block excitatory synaptic responses and GGP to block GABAB responses. The enhanced inhibition appeared to come about by a presynaptic action on GABA nerve terminals, because spontaneous inhibitory postsynaptic current (IPSC) frequency was increased with no change in the amplitude of postsynaptic currents, both in the presence and absence of tetrodotoxin used to block interneuron action potentials and cadmium used to block calcium influx into nerve terminals. The toluene-induced increase in mIPSC frequency was blocked by dantrolene or ryanodine, indicating that the abused inhalant acted to increase the release of calcium from intracellular nerve terminal stores. This presynaptic action produced by abused inhalants is shared by inhaled anesthetics and would contribute to the altered behavioral effects produced by both classes of drugs, and could be especially important in the context of a disruption of learning and memory by abused inhalants.
Over the past 10 years, solvent abuse has increased among grade-school children, adolescents, and some adults. The Monitoring the Future Survey (2000) found that 8th graders reported a high rate of current (4.5 percent), past year (10.2 percent), and lifetime (17.9 percent) inhalant abuse. The National Household Survey on Drug Abuse (2001) indicates that abuse of inhalants outpaced both crack cocaine and heroin use among young adults. In addition, abused inhalants are a major ‘gateway’ drug—leading to abuse of alcohol and other drugs. Recent data from the National Survey on Drug Use (2006) reported that over 7 83 000 initiates aged 12 or more have tried inhalants. Despite this widespread usage, there is little known about the effects of inhaled solvents on the nervous system (Balster, 1998; Del Re et al, 2006; Lubman et al, 2008).
Abused inhalant solvents could share similar actions with inhalational anesthetics, because both types of chemicals are halogenated or are aromatic hydrocarbons, and because volatile anesthetics also have a history of abuse potential (Balster, 1998; Beckstead et al, 2000; Bowen et al, 1999a). Also like anesthetics, abused inhalants exhibit nonselective actions on a number of neurotransmitter- and voltage-gated ion channels (Bale et al, 2005; Cruz et al, 2000; Del Re et al, 2006; Shafer et al, 2005; Smothers and Woodward, 2007). Synaptic sites of action play a major role for inhalational anesthetic effects on the central nervous system (Pittson et al, 2004; Pocock and Richards, 1991). Anesthetics enhance inhibitory synaptic responses (Nicoll et al, 1975; Nishikawa and MacIver, 2000, 2001). Early research indicated that amino-acid transmitters in hippocampal cortex were altered by abused inhalant exposure in animals (Bjornaes and Naalsund, 1988; Briving et al, 1986) and more recent work demonstrates effects on isolated GABA and glutamate receptors (Bale et al, 2005; Bowen et al, 1999b; Cruz et al, 2000), and chronic exposure alters GABA synapses (Liu et al, 2007); and these effects could alter inhibitory synaptic transmission. Toluene can directly excite ventral tegmental area dopaminergic neurons recorded in brain slices (Riegel et al, 2007). Toluene also stimulated nondopaminergic cells in vitro (Riegel et al, 2007), but not in vivo (Riegel and French, 1999), suggesting additional depressant effects to enhance GABAergic inhibition could be involved (Riegel et al, 2004; Riegel et al, 2007).
A previous study using field potential recordings in hippocampal slices found that toluene could inhibit synaptically evoked CA1 neuron population spikes (Ikeuchi and Hirai, 1994), suggesting that enhanced inhibition could occur. CA1 neuron GABA-mediated synaptic inhibition is enhanced during anesthesia in vivo (Ma and Leung, 2006; MacIver et al, 1996; Nicoll et al, 1975; Pearce et al, 1989) and abused inhalants could produce similar alterations, because abused inhalants can produce anesthesia and inhaled anesthetics produce some behavioral changes similar to abused inhalants in mice (Balster, 1998). This study compared effects produced by abused inhalants on GABA-mediated inhibitory synapses, using whole-cell patch clamp recordings from CA1 pyramidal cells in rat hippocampal brain slices. Three abused solvents were compared, two halogenated hydrocarbons (1,1,1-trichloroethane and trichloroethylene), as well as the aromatic agent, toluene, providing representation of inhalants with distinct chemical profiles.
MATERIALS AND METHODS
Brain slice preparation methods have previously been described in detail (Bieda and MacIver, 2004). In short, standard transverse hippocampal slices (450 μm) from adolescent Sprague–Dawley rats (P33–36) were prepared using a vibratome. All procedures conform to Society for Neuroscience and NIH guidelines and were approved by the Stanford University Animal Use Committee.
Standard visualized slice procedures were used (). All recordings were from CA1 pyramidal neurons in stratum pryamidale. Pyramidal neurons exhibited accommodating action potential trains in response to depolarizing current injection, but varied in resting membrane potential and threshold current required to produce spiking; there was no spontaneous spiking evident. Input resistances varied from 200 to 550 MΩ. There were no obvious differences between cells in response to toluene: every neuron displayed only a small decrease in spiking and input resistance. Throughout current-clamp experiments, sets of current steps were applied repetitively at fixed intervals (typically, 3 steps/set: 1 hyperpolarizing, one at zero pA, and 1 depolarizing; 1 set/min). The depolarizing current step was adjusted to produce seven action potentials during the depolarization in control conditions for each neuron. In both current-clamp and voltage-clamp experiments cells were allowed to remain at rest, tonic currents were not applied to adjust resting potentials. All experiments were conducted at room temperature (22–23°C) using a submersion chamber and perfusion vessels, valves and >95% of connectors and tubing were Teflon to minimize drug loss or binding. Using continuous perfusion of ACSF at 3 ml/min complete bath replacement took <30 s, as measured by dye exchange. Each slice was used for only a single experiment, and each animal provided 1–3 slices—limited by the long duration of each experiment (1–3 h). The following external (ACSF) was used (in mM): 124 NaCl, 3.5 KCl, 1.25 NaH2PO4, 2 MgSO4, 2 CaCl2, 26 NaHCO3, 10 glucose; it was bubbled with 95% O2/5% CO2 to reach pH 7.4. To prevent loss of the abused inhalant from the perfusate, a known volume of inhalant was added to pregassed ACSF and stored in Teflon perfusion vessels. Preliminary experiments showed that this prevented loss of volatile agents (less than 5% in 5 h) measured using high pressure liquid chromatography (HPLC; see below). A similar degree of loss was evident from samples taken next to brain slices in the experimental chamber used for recording neuronal responses.
We used standard whole-cell methods (pipette resistance 4–6 MΩ). For all current-clamp recordings a KGluconate-based internal solution was used (in mM): 100 KGluconate, 10 EGTA, 5 MgCl2, 40 HEPES, 2 Na2ATP, 0.3 NaGTP (pH 7.2 with KOH). For voltage-clamp experiments, a KCl internal-based solution with QX-314 (1–5 mM) to block sodium currents was used, and, in experiments on evoked IPSCs, the concentration of MgCl2 was changed to 3 mM. KCl internal was 100 KCl, 10 EGTA, 5 MgCl2, 40 HEPES, 2 Na2ATP, 0.3 NaGTP, 1 QX-314 (pH 7.2 with KOH).
Slice viability was tested using population spike responses and only slices exhibiting response amplitudes >10 mV were used for subsequent experiments. For recording of population spikes from CA1 pyramidal cells, an ACSF filled pipette (2 to 4 MΩ) was placed at the boarder of stratum pyramidale and stratum oriens. To stimulate synaptic inputs, a bipolar tungsten electrode was placed in stratum radiatum, as previously described.(Bieda et al, 2009) Recordings were established for >15 min before recording baseline data, and preparations showing unstable response properties (>5% variability) were not used.
Compounds and Concentration Analysis
All compounds were reagent grade or better from Sigma/RBI (St Louis, MO), except for toluene, tricholorethane, and trichloroethylene (all >99.99%), which were obtained from Aldrich (Milwaukee, WI). All solutions were made fresh daily using HPLC grade ‘OmniSolv’ water obtained from EMD–Merck (Gibbstown, NJ).
Due to the volatile nature of the abused inhalants, it was essential to measure bath concentrations to determine the extent of loss of drug from the perfusion vessels, tubing, and brain slice chamber. Chemical analysis was performed on ACSF samples (1.5 ml) taken from the perfusate and run on an HP 1050 HPLC using a 40/60% (water/acetonitrile) carrier solvent on a 25 cm spherisorb column. Major detection peaks for concentration analysis were found at 225 and 240 nm wavelengths with a retention time of approximately 8.5 min.
Data Collection and Analysis
Whole-cell and synaptically evoked responses were collected and analyzed online using Igor Pro 6.0 (Wavemetrics, Oswego, OR) and graphed on computer monitors to ensure that consistent baselines were established for each preparation. A two-tailed Student's t-test or repeated measures ANOVA with Tukey test were used to evaluate statistical significance (p<0.05 or less; GraphPad Prism software; Prism Inc., San Diego, CA, USA).
Abused Inhalants Produce Little Effect on Postsynaptic Excitability
Even at high concentrations, toluene produced only a small depression of CA1 neuron excitability (Figure 1), measured as an ability to generate action potentials in response to depolarizing current injection. There was no effect apparent on action potential peak amplitude, rise time, half-width, or decay phase. At a concentration of 1 mM, toluene depressed action potential discharge from seven spikes in control to 6.2±0.7 (mean±SD) spikes in the presence of the inhalant (Figure 1a). Although this depression was statistically significant (p<0.05; n=10 experiments, each from different slices, from 8 rats), only a minor degree of inhibition was evident. The depression of spike discharge was not accompanied by a change in the resting membrane potential of CA1 neurons, although a small, statistically insignificant, decrease in membrane resistance was observed.
To determine whether the depression of action potential discharge was due to an inhalant-induced enhancement of synaptic inhibition, the ability of a GABA receptor antagonist to reverse the depression was studied. The GABA receptor antagonist, gabazine (SR95531) at a saturating concentration (10 μM) completely reversed the inhalant-induced depression of discharge (8.1±0.6 spikes), indicating that an increase in GABA-mediated inhibition could account for this depression. Gabazine also reversed the small change in membrane resistance that was observed, but the difference was only significant at the p<0.05 level when gabazine data were compared to the normalized resistance in the presence of toluene (Figure 1b). Gabazine alone had no effect on action potential amplitude, rise time, duration, or on resting membrane potential.
Abused Inhalants Enhanced GABA-Mediated Synaptic Inhibition
To study the effects of abused inhalants on GABA-mediated inhibition, isolated, monosynaptic inhibitory postsynaptic potentials (IPSPs) were evoked with stimulating electrodes placed in stratum radiatum. Glutamate and GABA-B-mediated synaptic responses were blocked using receptor antagonists—CNQX (18 μM and APV 100 μM) and CGP (1.0 μM), respectively. Stimulus location, within stratum radiatum, as well as intensities and polarity were adjusted to produce minimal, stable response amplitudes; typically about 1.5 times threshold for the smallest amplitude responses seen. Using this approach, IPSPs exhibited amplitudes from 5 to 15 mV and failure rates of approximately 20%. The abused inhalants increased IPSP amplitudes, but did not appear to alter the rise time, decay time, duration, or failure rate of these synaptic responses (Figure 2).
Toluene (TOL), trichloroethane (TCE), and trichloroethylene (TCY) appeared to be equally efficacious at increasing GABA-mediated inhibition, enhancing IPSP amplitudes to 129±2.3, 128±1.6, and 127±0.9% of control responses, respectively. The inhalants differed considerably, however, in potencies with a rank order of TCY>TOL>TCE over a twofold range of concentrations. The concentration producing a half maximal effect (EC50) was determined from Hill equations, fitting the data with a least squares approach. The TCY EC50 was 360 μM, and EC50 for TOL and TCE were 628 μM and 895 μM, respectively. Hill coefficients also varied considerably: 1.2 for TCE, 2.7 for TOL, and 4.7 for TCY.
Abused Inhalants Enhanced GABA-Mediated Synaptic Inhibition by a Presynaptic Action
To determine whether the enhanced GABA-mediated inhibition resulted from pre- or postsynaptic mechanisms of action, spontaneous inhibitory postsynaptic currents (IPSCs) were recorded from voltage-clamped CA1 neurons (Figure 3). In control conditions, IPSC amplitudes ranged from 2 pA, just detectable above noise, to 650 pA with an average amplitude of 75.8±14.2 pA seen across 23 720 events recorded from 10 CA1 neurons. Frequency varied considerably, even within each cell, but averaged 4.3±1.7 Hz. IPSC rise time (1.58±0.21 ms), decay time (16.9±5.2 ms), and duration (24.6±7.8 ms) measurements were quite consistent across cells. These IPSCs were completely blocked with 20 μM gabazine (not shown), indicating that they were GABA-mediated synaptic currents.
All three abused inhalants significantly increased IPSC frequency: TOL to 134±5.6% of control, TCE to 130±6.3% and TCY to 123±7.1% of control, for concentrations of 940 μM TOL, and 800 μM of both TCE and TCY (Figure 3). These frequency increases were not accompanied by any measurable effect on holding currents needed to maintain the resting membrane potential at the original control values for the CA1 neurons. No significant effects on IPSC amplitude, rise time, decay time, or duration were observed in the presence of any abused inhalant. Thus, the abused inhalant-induced increase in inhibition appears to come about by a presynaptic action to increase the release of GABA from inhibitory nerve terminals.
Abused Inhalants Act Directly on GABA Nerve Terminals
The increased IPSC frequency produced by the inhalants could have come about by increased discharge of action potentials in inhibitory interneurons, or by a direct effect on interneuron nerve terminals. To test whether either or both of these effects contribute to the increased IPSC frequency, miniature IPSCs (mIPSCs) were recorded in the presence of TTX (1.0 μM) to block sodium channels, and, hence, abolish action potential discharge of inhibitory neurons. If the inhalant-induced increase in mIPSC frequency still occurred, then a direct action on GABA nerve terminals would be implicated.
In control conditions, mIPSC amplitudes were much smaller than IPSCs, averaging 27.4±5.3 pA. Rise times and decay times were essentially the same as seen for control conditions in the absence of TTX, however, mIPSC frequency was reduced to 3.25±1.89 Hz across the 9189 events recorded from 10 CA1 neurons studied. In the neuron shown in Figure 4b, toluene (940 μM) produced a near doubling in mIPSC frequency (from 5.5 to 8.3 Hz), that reached steady state within 10 min and recovered following removal of toluene within 20 min. All of these synaptic currents were blocked by 20 μM gabazine applied at 50 min. Grouped data for all 10 experiments are shown in Figure 4c and the increased frequency of mIPSCs was statistically significant (p<0.01), as was the gabazine block (p<0.001), both compared to control frequencies measured before application of drug.
For the majority of experiments (7 of 10), mIPSC amplitude, rise time, decay time, and duration were not altered by the inhalant. In the remaining three experiments, an apparent toluene-induced increase in rise time (from 1.78±0.63 to 2.55±0.98 ms), decay time (from 17.11±11.23 to 29.87±28.65 ms), and duration was seen in the initial analysis. On closer inspection, it was evident that these cells had prominent GABAA Slow mIPSCs mixed in amongst the typical GABAA Fast responses seen during control recordings (Figure 5). Toluene appeared to have a selective effect to enhance the frequency of GABAA Slow mIPSCs (to 120% of control) in these cells and this produced an apparent increase in decay time and duration, because more slow events were contributing to the analysis in the presence of inhalant.
Previous studies have shown that volatile anesthetics increase mIPSC frequency by acting on intracellular calcium stores in GABA nerve terminals(Doze and MacIver, 1998; Yamashita et al, 2001). To determine whether a similar mechanism contributed to the toluene-induced increase in mIPSC frequency, the effects of blocking calcium influx into nerve terminals was studied. The toluene-induced increase in mIPSC frequency persisted in the presence of 500 μM Cd++, used to block calcium entry into nerve terminals, thus, toluene appeared to share an action on intracellular stores with volatile anesthetics. Nerve terminals appear to have at least two intracellular calcium storage compartments: a thapsigargin-sensitive store that is associated with IP3 receptor-mediated regulation and a caffeine-sensitive store that is associated with ryanodine receptor-mediated regulation. Thapsigargin, ryanodine, or dantrolene, when applied alone, appeared not to alter mIPSC frequency, except for a transient increase (2–5 min) following dantrolene exposure. Pretreatment of preparations with thapsigargin did not alter the toluene-induced increase in mIPSC frequency (Figure 6), however, pretreatment with either dantrolene (a calcium store depletion agent) or ryanodine (a caffeine store calcium channel blocker) blocked the effect produced by toluene.
Abused inhalants depressed CA1 pyramidal neurons by increasing inhibition at GABA synapses. All three inhalants appeared to increase inhibition over the concentration range thought to occur in vivo (Balster, 1987; Beckstead et al, 2000). This increased inhibition was evident in recordings of monosynaptic IPSPs and occurred with no apparent effect on resting membrane potential or action potential threshold produced by the inhalants. The increased inhibition appeared to come about by a presynaptic mechanism, because it was associated with an increase in spontaneous IPSC frequency with no effect on postsynaptic current amplitudes. The increased IPSC frequency appeared to involve actions directly on GABA nerve terminals, because the effect persisted after blockade of action potentials secondary to blocking sodium channels with tetrodotoxin. Similarly, the toluene effect persisted after blocking calcium influx into nerve terminals, indicating that the increased mIPSC frequency involved a toluene-induced release of calcium from intracellular stores. The increase in mIPSC frequency was blocked by pretreatment with either dantrolene or ryanodine, but not by thapsigargin, indicating that toluene caused a release of calcium from a caffeine-sensitive store, but not from an IP3-regulated store. In this respect, the abused inhalants appear to act via a mechanism that is similar to that used by inhaled anesthetics.
Enhanced GABA-mediated inhibition is a common effect produced by inhaled anesthetics, such as halothane and isoflurane (Banks and Pearce, 1999; Bieda et al, 2009; Franks, 2008; Jones and Harrison, 1993; ; Tanelian et al, 1993). As this is a prevalent effect seen in hippocampal neurons, it has been proposed to play a role in anesthetic-induced memory loss (Simon et al, 2001; Tanelian et al, 1993). Indeed, volatile anesthetics have been shown to block long-term potentiation (MacIver et al, 1989) and long-term depression at CA1 neuron synapses (Ishizeki et al, 2008; Simon et al, 2001), as do other anesthetics (Cheng et al, 2006). The selective enhancement of GABAA Slow mIPSCs observed could be particularly important in this regard because these synaptic currents have the ideal time course to modulate NMDA responses (Banks et al, 2000), which are critical for synaptic plasticity in several major synaptic pathways. These forms of synaptic plasticity are widely thought to contribute to hippocampal-dependent learning and memory, as well as to some long-term mechanisms of drug addiction (Hyman et al, 2006). Thus, the enhanced GABA-mediated inhibition seen in this study would provide a mechanism for the disruption of learning and memory that is produced by abused inhalants (Bowen et al, 2006). It should be noted that good evidence exists for additional effects of abused solvents that could also impair learning mechanisms, in particular actions on NMDA receptors and other neurotransmitter systems, and brain regions, would be very likely to contribute (Beckstead et al, 2000; Riegel et al, 2007; Smothers and Woodward, 2007; Woodward et al, 2004).
Although anesthetics and abused inhalants both increase GABA-mediated inhibition, important differences in the mechanism of action were seen. Anesthetics enhance inhibition by at least three distinct actions: (1) a presynaptic effect similar to that seen here (ie, an increased frequency of IPSCs; Banks and Pearce, 1999; Yamashita et al, 2001); (2) a postsynaptic effect to prolong synaptic inhibition (Mody et al, 1991; Nicoll et al, 1975; Pittson et al, 2004); and (3) a postsynaptic effect to enhance tonic (extrasynaptic) GABA-gated currents (Bieda and MacIver, 2004; Bieda et al, 2009; Caraiscos et al, 2004). Abused inhalants, in contrast, shared only the first (presynaptic) effect with inhaled anesthetics, and neither of the postsynaptic actions were evident. This enhanced presynaptic release of GABA has also been observed for ethanol (Weiner and Valenzuela, 2006). Prolongation of IPSCs, such as an increase in decay time or duration, was not produced. Neither was an increase in tonic, extrasynaptic currents evident in either current-clamp or voltage-clamp experiments. Perhaps it is only the presynaptic effects of the anesthetics and abused inhalants that are needed to disrupt learning and memory, whereas the postsynaptic actions contribute to sedation and loss of consciousness produced by the inhaled anesthetics. The relatively weak anesthetic properties of abused inhalants are consistent with the lack of postsynaptic actions seen in this study, of course it might only reflect a more limited degree of enhanced inhibition too, regardless of pre- or postsynaptic sites of action.
In summary, abused inhalants increased synaptic inhibition in hippocampal neurons and this likely contributes to learning deficits associated with solvent abuse.
Bale AS, Tu Y, Carpenter-Hyland EP, Chandler LJ, Woodward JJ (2005). Alterations in glutamatergic and gabaergic ion channel activity in hippocampal neurons following exposure to the abused inhalant toluene. Neuroscience 130: 197–206.
Balster RL (1987). Abuse potential evaluation of inhalants. Drug Alcohol Depend 19: 7–15.
Balster RL (1998). Neural basis of inhalant abuse. Drug Alcohol Depend 51: 207–214.
Banks MI, Pearce RA (1999). Dual actions of volatile anesthetics on GABA(A) IPSCs: dissociation of blocking and prolonging effects.[see comment]. Anesthesiology 90: 120–134.
Banks MI, White JA, Pearce RA (2000). Interactions between distinct GABA(A) circuits in hippocampus. Neuron 25: 449–457.
Beckstead MJ, Weiner JL, Eger 2nd EI, Gong DH, Mihic SJ (2000). Glycine and gamma-aminobutyric acid(A) receptor function is enhanced by inhaled drugs of abuse. Mol Pharmacol 57: 1199–1205.
Bieda MC, MacIver MB (2004). Major role for tonic GABAA conductances in anesthetic suppression of intrinsic neuronal excitability. J Neurophysiol 92: 1658–1667.
Bieda MC, Su H, MacIver MB (2009). Anesthetics discriminate between tonic and phasic gamma-aminobutyric acid receptors on hippocampal CA1 neurons. Anesth Analg 108: 484–490.
Bjornaes S, Naalsund LU (1988). Biochemical changes in different brain areas after toluene inhalation. Toxicology 49: 367–374.
Bowen SE, Batis JC, Paez-Martinez N, Cruz SL (2006). The last decade of solvent research in animal models of abuse: mechanistic and behavioral studies. Neurotoxicol Teratol 28: 636–647.
Bowen SE, Daniel J, Balster RL (1999a). Deaths associated with inhalant abuse in Virginia from 1987 to 1996. Drug Alcohol Depend 53: 239–245.
Bowen SE, Wiley JL, Jones HE, Balster RL (1999b). Phencyclidine- and diazepam-like discriminative stimulus effects of inhalants in mice. Exp Clin Psychopharmacol 7: 28–37.
Briving C, Jacobson I, Hamberger A, Kjellstrand P, Haglid KG, Rosengren LE (1986). Chronic effects of perchloroethylene and trichloroethylene on the gerbil brain amino acids and glutathione. Neurotoxicology 7: 101–108.
Caraiscos VB, Newell JG, You-Ten KE, Elliott EM, Rosahl TW, Wafford KA et al (2004). Selective enhancement of tonic GABAergic inhibition in murine hippocampal neurons by low concentrations of the volatile anesthetic isoflurane. J Neurosci 24: 8454–8458.
Cheng VY, Martin LJ, Elliott EM, Kim JH, Mount HT, Taverna FA et al (2006). Alpha5GABAA receptors mediate the amnestic but not sedative-hypnotic effects of the general anesthetic etomidate. J Neurosci 26: 3713–3720.
Cruz SL, Balster RL, Woodward JJ (2000). Effects of volatile solvents on recombinant N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Br J Pharmacol 131: 1303–1308.
Del Re AM, Dopico AM, Woodward JJ (2006). Effects of the abused inhalant toluene on ethanol-sensitive potassium channels expressed in oocytes. Brain Res 1087: 75–82.
Doze VA, MacIver MB (1998). Halothane enhances presynaptic spontaneous gaba release by increasing calcium release from ryanodine sensitive stores. Soc Neurosci 24: 349.
Franks NP (2008). General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal. Nat Rev Neurosci 9: 370–386.
Hyman SE, Malenka RC, Nestler EJ (2006). Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29: 565–598.
Ikeuchi Y, Hirai H (1994). Toluene inhibits synaptic transmission without causing gross morphological disturbances. Brain Res 664: 266–270.
Ishizeki J, Nishikawa K, Kubo K, Saito S, Goto F (2008). Amnestic concentrations of sevoflurane inhibit synaptic plasticity of hippocampal CA1 neurons through gamma-aminobutyric acid-mediated mechanisms. Anesthesiology 108: 447–456.
Jones MV, Harrison NL (1993). Effects of volatile anesthetics on the kinetics of inhibitory postsynaptic currents in cultured rat hippocampal neurons. J Neurophysiol 70: 1339–1349.
Liu CL, Lin YR, Chan MH, Chen HH (2007). Effects of toluene exposure during brain growth spurt on GABA(A) receptor-mediated functions in juvenile rats. Toxicol Sci 95: 443–451.
Lubman DI, Yucel M, Lawrence AJ (2008). Inhalant abuse among adolescents: neurobiological considerations. Br J Pharmacol 154: 316–326.
Ma J, Leung LS (2006). Limbic system participates in mediating the effects of general anesthetics. Neuropsychopharmacology 31: 1177–1192.
MacIver MB, Mandema JW, Stanski DR, Bland BH (1996). Thiopental uncouples hippocampal and cortical synchronized electroencephalographic activity. Anesthesiology 84: 1411–1424.
MacIver MB, Tauck DL, Kendig JJ (1989). General anaesthetic modification of synaptic facilitation and long-term potentiation in hippocampus. Br J Anaesth 62: 301–310.
Mody I, Tanelian DL, MacIver MB (1991). Halothane enhances tonic neuronal inhibition by elevating intracellular calcium. Brain Res 538: 319–323.
Nicoll RA, Eccles JC, Oshima T, Rubia F (1975). Prolongation of hippocampal inhibitory postsynaptic potentials by barbiturates. Nature 258: 625–627.
Nishikawa K, MacIver MB (2000). Membrane and synaptic actions of halothane on rat hippocampal pyramidal neurons and inhibitory interneurons. J Neurosci 20: 5915–5923.
Nishikawa K, MacIver MB (2001). Agent-selective effects of volatile anesthetics on GABAA receptor-mediated synaptic inhibition in hippocampal interneurons. Anesthesiology 94: 340–347.
Pearce RA, Stringer JL, Lothman EW (1989). Effect of volatile anesthetics on synaptic transmission in the rat hippocampus. Anesthesiology 71: 591–598.
Pittson S, Himmel AM, MacIver MB (2004). Multiple synaptic and membrane sites of anesthetic action in the CA1 region of rat hippocampal slices. BMC Neurosci 5: 52.
Pocock G, Richards CD (1991). Cellular mechanisms in general anaesthesia. Br J Anaesth 66: 116–128.
Riegel AC, Ali SF, Torinese S, French ED (2004). Repeated exposure to the abused inhalant toluene alters levels of neurotransmitters and generates peroxynitrite in nigrostriatal and mesolimbic nuclei in rat. Ann NY Acad Sci 1025: 543–551.
Riegel AC, French ED (1999). An electrophysiological analysis of rat ventral tegmental dopamine neuronal activity during acute toluene exposure. Pharmacol Toxicol 85: 37–43.
Riegel AC, Zapata A, Shippenberg TS, French ED (2007). The abused inhalant toluene increases dopamine release in the nucleus accumbens by directly stimulating ventral tegmental area neurons. Neuropsychopharmacology 32: 1558–1569.
Shafer TJ, Bushnell PJ, Benignus VA, Woodward JJ (2005). Perturbation of voltage-sensitive Ca2+ channel function by volatile organic solvents. J Pharmacol Exp Ther 315: 1109–1118.
Simon W, Hapfelmeier G, Kochs E, Zieglgansberger W, Rammes G (2001). Isoflurane blocks synaptic plasticity in the mouse hippocampus. Anesthesiology 94: 1058–1065.
Smothers CT, Woodward JJ (2007). Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits. J Pharmacol Exp Ther 322: 739–748.
Tanelian DL, Kosek P, Mody I, MacIver MB (1993). The role of the GABAA receptor/chloride channel complex in anesthesia. Anesthesiology 78: 757–776.
Weiner JL, Valenzuela CF (2006). Ethanol modulation of GABAergic transmission: the view from the slice. Pharmacol Ther 111: 533–554.
Woodward JJ, Nowak M, Davies DL (2004). Effects of the abused solvent toluene on recombinant P2X receptors expressed in HEK293 cells. Brain Res Mol Brain Res 125: 86–95.
Yamashita M, Ueno T, Akaike N, Ikemoto Y (2001). Modulation of miniature inhibitory postsynaptic currents by isoflurane in rat dissociated neurons with glycinergic synaptic boutons. Eur J Pharmacol 431: 269–276.
I thank Marin MacDonald and Patricia Turnquist for technical assistance with brain slice preparation and electrophysiology. I thank Eric Hu for technical assistance with HPLC analysis and Professor James R Trudell for HPLC assistance, guidance and advice about the use and chemical properties of the abused inhalants throughout this project. Dr JJ Woodward and Dr RA Pearce provided helpful comments and suggestions on portions of this work.
Research support was provided by NIH: NIDA R01DA017884, and I am thankful for the encouragement and guidance provided by Dr Charles Sharp and Dr Jerry Frankenheim at NIDA.
DISCLOSURE/CONFLICT OF INTEREST
The author declares that no financial support or compensation has been received from any individual or corporate entity and there are no personal financial holdings that could be perceived as constituting a real or potential conflict of interest in this work.
About this article
Cite this article
MacIver, M. Abused Inhalants Enhance GABA-Mediated Synaptic Inhibition. Neuropsychopharmacol 34, 2296–2304 (2009). https://doi.org/10.1038/npp.2009.57
- endoplasmic reticulum
This article is cited by
Delta-opioid receptor-mediated modulation of excitability of individual hippocampal neurons: mechanisms involved
Pharmacological Reports (2021)
International Journal of Legal Medicine (2015)
CNS Drugs (2012)
The Abused Inhalant Toluene Differentially Modulates Excitatory and Inhibitory Synaptic Transmission in Deep-Layer Neurons of the Medial Prefrontal Cortex